Corneal chromoblastomycosis

K. Barton, Darlene Miller, S. C. Pflugfelder

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose. We sought to illustrate the difficulty in managing uncommon, pigmented mold-related corneal ulceration and to highlight the role of itraconazole in treating these patients. Method. We describe the management and clinical course of a patient with a recurring corneal infection caused by Fonsecaea pedrosoi and discuss this experience in the light of existing literature on management of cutaneous chromoblastomycosis. Results. A corneal ulcer caused by this organism healed initially on treatment with topical and systemic antifungal medication, but infection recurred in the deep stroma 4 months after cessation of therapy. After failure to respond to a further period of medical therapy, a small therapeutic penetrating keratoplasty was performed. Culture of a fibrinous membrane from the anterior iris surface demonstrated intraocular fungal infection, and postoperatively, an episode of marked fibrinous uveitis developed, suggesting the presence of viable intraocular fungal elements. A large penetrating keratoplasty was therefore performed with excision of involved iris in combination with extracapsular cataract extraction. F. pedrosoi was again cultured from the fibrinous membrane adherent to the iris and from the anterior lens capsule. Postoperatively the patient received a 5-month course of systemic itraconazole, and no further recurrences have been encountered after a further 2 months. Conclusion. F pedrosoi is the organism most commonly isolated from the chronic cutaneous mycosis, chromoblastomycosis, and is relatively resistant to medical therapy. As has been reported for cutaneous disease, surgery in combination with systemic itraconazole may provide the best chance of cure in corneal chromoblastomycosis.

Original languageEnglish
Pages (from-to)235-239
Number of pages5
JournalCornea
Volume16
Issue number2
StatePublished - Mar 1 1997

Fingerprint

Chromoblastomycosis
Itraconazole
Iris
Penetrating Keratoplasty
Mycoses
Anterior Capsule of the Lens
Dermatologic Surgical Procedures
Corneal Ulcer
Therapeutics
Skin
Membranes
Cataract Extraction
Uveitis
Infection
Skin Diseases
Fungi
Recurrence

Keywords

  • Chromoblastomycosis
  • Fonsecaea pedrosoi
  • Fungus
  • Infection
  • Itraconazol
  • Keratitis
  • Therapeutic keratoplasty

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Barton, K., Miller, D., & Pflugfelder, S. C. (1997). Corneal chromoblastomycosis. Cornea, 16(2), 235-239.

Corneal chromoblastomycosis. / Barton, K.; Miller, Darlene; Pflugfelder, S. C.

In: Cornea, Vol. 16, No. 2, 01.03.1997, p. 235-239.

Research output: Contribution to journalArticle

Barton, K, Miller, D & Pflugfelder, SC 1997, 'Corneal chromoblastomycosis', Cornea, vol. 16, no. 2, pp. 235-239.
Barton K, Miller D, Pflugfelder SC. Corneal chromoblastomycosis. Cornea. 1997 Mar 1;16(2):235-239.
Barton, K. ; Miller, Darlene ; Pflugfelder, S. C. / Corneal chromoblastomycosis. In: Cornea. 1997 ; Vol. 16, No. 2. pp. 235-239.
@article{dc17b0c560994fa1b6da88b4f9f553cd,
title = "Corneal chromoblastomycosis",
abstract = "Purpose. We sought to illustrate the difficulty in managing uncommon, pigmented mold-related corneal ulceration and to highlight the role of itraconazole in treating these patients. Method. We describe the management and clinical course of a patient with a recurring corneal infection caused by Fonsecaea pedrosoi and discuss this experience in the light of existing literature on management of cutaneous chromoblastomycosis. Results. A corneal ulcer caused by this organism healed initially on treatment with topical and systemic antifungal medication, but infection recurred in the deep stroma 4 months after cessation of therapy. After failure to respond to a further period of medical therapy, a small therapeutic penetrating keratoplasty was performed. Culture of a fibrinous membrane from the anterior iris surface demonstrated intraocular fungal infection, and postoperatively, an episode of marked fibrinous uveitis developed, suggesting the presence of viable intraocular fungal elements. A large penetrating keratoplasty was therefore performed with excision of involved iris in combination with extracapsular cataract extraction. F. pedrosoi was again cultured from the fibrinous membrane adherent to the iris and from the anterior lens capsule. Postoperatively the patient received a 5-month course of systemic itraconazole, and no further recurrences have been encountered after a further 2 months. Conclusion. F pedrosoi is the organism most commonly isolated from the chronic cutaneous mycosis, chromoblastomycosis, and is relatively resistant to medical therapy. As has been reported for cutaneous disease, surgery in combination with systemic itraconazole may provide the best chance of cure in corneal chromoblastomycosis.",
keywords = "Chromoblastomycosis, Fonsecaea pedrosoi, Fungus, Infection, Itraconazol, Keratitis, Therapeutic keratoplasty",
author = "K. Barton and Darlene Miller and Pflugfelder, {S. C.}",
year = "1997",
month = "3",
day = "1",
language = "English",
volume = "16",
pages = "235--239",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Corneal chromoblastomycosis

AU - Barton, K.

AU - Miller, Darlene

AU - Pflugfelder, S. C.

PY - 1997/3/1

Y1 - 1997/3/1

N2 - Purpose. We sought to illustrate the difficulty in managing uncommon, pigmented mold-related corneal ulceration and to highlight the role of itraconazole in treating these patients. Method. We describe the management and clinical course of a patient with a recurring corneal infection caused by Fonsecaea pedrosoi and discuss this experience in the light of existing literature on management of cutaneous chromoblastomycosis. Results. A corneal ulcer caused by this organism healed initially on treatment with topical and systemic antifungal medication, but infection recurred in the deep stroma 4 months after cessation of therapy. After failure to respond to a further period of medical therapy, a small therapeutic penetrating keratoplasty was performed. Culture of a fibrinous membrane from the anterior iris surface demonstrated intraocular fungal infection, and postoperatively, an episode of marked fibrinous uveitis developed, suggesting the presence of viable intraocular fungal elements. A large penetrating keratoplasty was therefore performed with excision of involved iris in combination with extracapsular cataract extraction. F. pedrosoi was again cultured from the fibrinous membrane adherent to the iris and from the anterior lens capsule. Postoperatively the patient received a 5-month course of systemic itraconazole, and no further recurrences have been encountered after a further 2 months. Conclusion. F pedrosoi is the organism most commonly isolated from the chronic cutaneous mycosis, chromoblastomycosis, and is relatively resistant to medical therapy. As has been reported for cutaneous disease, surgery in combination with systemic itraconazole may provide the best chance of cure in corneal chromoblastomycosis.

AB - Purpose. We sought to illustrate the difficulty in managing uncommon, pigmented mold-related corneal ulceration and to highlight the role of itraconazole in treating these patients. Method. We describe the management and clinical course of a patient with a recurring corneal infection caused by Fonsecaea pedrosoi and discuss this experience in the light of existing literature on management of cutaneous chromoblastomycosis. Results. A corneal ulcer caused by this organism healed initially on treatment with topical and systemic antifungal medication, but infection recurred in the deep stroma 4 months after cessation of therapy. After failure to respond to a further period of medical therapy, a small therapeutic penetrating keratoplasty was performed. Culture of a fibrinous membrane from the anterior iris surface demonstrated intraocular fungal infection, and postoperatively, an episode of marked fibrinous uveitis developed, suggesting the presence of viable intraocular fungal elements. A large penetrating keratoplasty was therefore performed with excision of involved iris in combination with extracapsular cataract extraction. F. pedrosoi was again cultured from the fibrinous membrane adherent to the iris and from the anterior lens capsule. Postoperatively the patient received a 5-month course of systemic itraconazole, and no further recurrences have been encountered after a further 2 months. Conclusion. F pedrosoi is the organism most commonly isolated from the chronic cutaneous mycosis, chromoblastomycosis, and is relatively resistant to medical therapy. As has been reported for cutaneous disease, surgery in combination with systemic itraconazole may provide the best chance of cure in corneal chromoblastomycosis.

KW - Chromoblastomycosis

KW - Fonsecaea pedrosoi

KW - Fungus

KW - Infection

KW - Itraconazol

KW - Keratitis

KW - Therapeutic keratoplasty

UR - http://www.scopus.com/inward/record.url?scp=0030899217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030899217&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 235

EP - 239

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 2

ER -